Response to the Letter to the Editor: Inborn Errors in Pediatric Intensive Care Unit: Much More to Understand
Journal of Pediatric Intensive Care · 01.09.2023 · 12 (03) · 243
DOI: 10.1055/s-0041-1731023 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Pediatric Intensive Care, erschienen am 01.09.2023. Verfasst von Patrícia Lipari Pinto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Intensivpflege
Abstract (Originalsprache)
Letter to: Inborn Errors of Metabolism in Pediatric Intensive Care Unit: Much More to Understand J Pediatr Intensive Care 2022; 11(04): 355-358 DOI: 10.1055/s-0041-1731022 Inborn Errors of Metabolism in Pediatric Intensive Care Unit: Much More to Understand We would like to thank you for the opportunity to respond to Dr. Puspraj Awasthi and Dr. Suresh Angurana's letter. We would also like to thank Dr. Puspraj Awasthi and Dr. Suresh Angurana for their interest in our article and for their comments.[ 1 ] In their letter to the editor, the authors mentioned that in India there is no universal screening for inborn errors of metabolism (IEM) and in some regions there is lack of testing facilities. In fact, our setting is quite different, as in Portugal the universal screening is free and was started in 1979 with phenylketonuria screening. It currently includes 24 IEMs, cystic fibrosis, and congenital hypothyroidism. In addition, our center is a referral hospital for metabolic disorders. As we mentioned in our paper,[ 2 ] our admission rate of IEM is similar to other specialized centres[ 3 ] and therefore slightly higher than in the studies mentioned by the authors.[ 4 ] [ 5 ] We agree with the authors that our lower mortality rates are probably related to an extensive newborn screening, concentration of patients in a major center, and availability of specialized human and technical resources. Certainly, neonatal screening and treatment in specialized centers are fundamental for the management of these highly complex patients. Publication History Received: 11 March 2021 Accepted: 16 April 2021 Article published online: 29 June 2021 © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Autor:innen und Institutionen
- Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
- Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
- Pediatric Intensive Care Unit, Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
- Metabolic Diseases Unit, Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
- Division of Genetics, Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
Zitieren
APA
Lipari Pinto, P., Shchomak, Z., Boto, L., Janeiro, P., Moldovan, O., Abecasis, F., Gaspar, A., & Vieira, M. (2023). Response to the Letter to the Editor: Inborn Errors in Pediatric Intensive Care Unit: Much More to Understand. Journal of Pediatric Intensive Care, 12(03), 243. https://doi.org/10.1055/s-0041-1731023
Vancouver
Lipari Pinto P, Shchomak Z, Boto L, Janeiro P, Moldovan O, Abecasis F, et al. Response to the Letter to the Editor: Inborn Errors in Pediatric Intensive Care Unit: Much More to Understand. Journal of Pediatric Intensive Care. 2023;12(03):243. doi:10.1055/s-0041-1731023
BibTeX
@article{LipariPinto2023,
author = {Lipari Pinto, Patrícia and Shchomak, Zakhar and Boto, Leonor and Janeiro, Patrícia and Moldovan, Oana and Abecasis, Francisco and Gaspar, Ana and Vieira, Marisa},
title = {Response to the Letter to the Editor: Inborn Errors in Pediatric Intensive Care Unit: Much More to Understand},
journal = {Journal of Pediatric Intensive Care},
year = {2023},
volume = {12},
number = {03},
pages = {243},
doi = {10.1055/s-0041-1731023}
}
EUVIMED